Incidental cerebral microbleeds and cerebral blood flow in elderly individuals

JAMA Neurology

Volumn 72, Issue 9, 2015, Pages 1021-1028

  Gregg, Nicholas M ^a   Kim, Albert E ^a   Gurol, M Edip ^b,c   Lopez, Oscar L ^a   Aizenstein, Howard J ^a   Price, Julie C ^a   Mathis, Chester A ^a   James, Jeffrey A ^a   Snitz, Beth E ^a   Cohen, Ann D ^a   Kamboh, M Ilyas ^d   Minhas, Davneet ^a   Weissfeld, Lisa A ^e   Tamburo, Erica L ^a   Klunk, William E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B; APOLIPOPROTEIN E;

AGED; AMYLOID NEUROPATHY; ARTICLE; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN METABOLISM; CEREBROVASCULAR DISEASE; CLINICAL DEMENTIA RATING; COGNITION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HUMAN; INCIDENTAL FINDING; MALE; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PREVALENCE; PRIORITY JOURNAL; RESTING STATE NETWORK; UNITED STATES; VERY ELDERLY; AGING; BRAIN CIRCULATION; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; GENETICS; INCIDENCE; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHYSIOLOGY; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84942256291     PISSN: 21686149     EISSN: 21686157     Source Type: Journal    
DOI: 10.1001/jamaneurol.2015.1359     Document Type: Article

References (30)

1. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2∗-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20(4):637-642.
2. Greenberg SM, Grabowski T, Gurol ME, et al. Detection of isolated cerebrovascular β-amyloid with Pittsburgh compound B. Ann Neurol. 2008;64(5):587-591.
3. Gurol ME, Dierksen G, Betensky R, et al. Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology. 2012;79(4):320-326.
4. Tatsumi S, Shinohara M, Yamamoto T. Direct comparison of histology of microbleeds with postmortem MR images: a case report. Cerebrovasc Dis. 2008;26(2):142-146.
5. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208-1214.
6. Okazaki H, Reagan TJ, Campbell RJ. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc. 1979;54(1):22-31.
7. Thal DR, Ghebremedhin E, Orantes M, Wiestler OD. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol. 2003;62(12):1287-1301.
8. Jeerakathil T, Wolf PA, Beiser A, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke. 2004;35(8):1831-1835.
9. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry. 2008;79(9):1002-1006.
10. Goos JD, Kester MI, Barkhof F, et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke. 2009;40(11):3455-3460.
11. Kirsch W, McAuley G, Holshouser B, et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis. 2009;17(3):599-609.
12. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. 2002;58(11):1629-1634.
13. Staekenborg SS, Koedam EL, Henneman WJ, et al. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke. 2009;40(4):1269-1274.
14. van der Vlies AE, Goos JD, Barkhof F, Scheltens P, van der Flier WM. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology. 2012;79(8):763-769.
15. Smith EE, Vijayappa M, Lima F, et al. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology. 2008;71(18):1424-1430.
16. Dumas A, Dierksen GA, Gurol ME, et al. Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol. 2012;72(1):76-81.
17. Peca S, McCreary CR, Donaldson E, et al. Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy. Neurology. 2013;81(19):1659-1665.
18. Chung YA, O JH, Kim JY, Kim KJ, Ahn KJ. Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med. 2009;50(12):1969-1974.
19. Hughes TM, Kuller LH, Barinas-Mitchell EJ, et al. Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. Neurology. 2013;81(19):1711-1718.
20. Snitz BE, Weissfeld LA, Lopez OL, et al. Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia. Neurology. 2013;80(15):1378-1384.
21. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414.
22. Greenberg SM, Vernooij MW, Cordonnier C, et al; Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol.2009;8(2):165-174.
23. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537-539.
24. Cohen AD, Price JC, Weissfeld LA, et al. Basal cerebral metabolism may modulate the cognitive effects of Aβ in mild cognitive impairment: an example of brain reserve. J Neurosci. 2009;29(47):14770-14778.
25. Liu TT, Brown GG. Measurement of cerebral perfusion with arterial spin labeling: part 1: methods. J Int Neuropsychol Soc. 2007;13(3):517-525.
26. Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26(3):839-851.
27. Yue NC, Arnold AM, Longstreth WT Jr, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the Cardiovascular Health Study. Radiology.1997;202(1):33-39.
28. Cheng C, Pounds SB, Boyett JM, Pei D, Kuo ML, Roussel MF. Statistical significance threshold criteria for analysis of microarray gene expression data. Stat Appl Genet Mol Biol. 2004;3:e36.
29. Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC; AIBL Research Group. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology. 2011;77(1):48-54.
30. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol.2007;62(3):229-234.